International Summit on Innovative Drug and Advanced Therapy Evaluation Research Held

On May 18, the International Summit on Innovative Drug and Advanced Therapy Evaluation Research, hosted by TUP and organized by the editorial offices of Cancer Innovation, Health Care Science, and Medicine Advances, was held in Suzhou, Jiangsu Province. During the event, the new book Non-Clinical Evaluation Studies on Cell and Gene Therapy Products (2nd Edition) was released.

Dr. LIU Yongjun, Chairman of the Specialized Committee on Quality Research of Cell and Gene Therapy Drugs under the China Quality Association for Pharmaceuticals, attended the event and delivered a speech. Professor KONG Fanpu, Chief Research Fellow of the School of Medicine from Tsinghua University gave keynote speeches. Dr. WANG Yaning, CEO of Createrna Technology gave an academic representation at the forum.

SUN Yu, Deputy General Editor of Tsinghua University Press, remarked that Non-Clinical Evaluation Studies on Cell and Gene Therapy Products (2nd Edition) is poised to become a valuable resource offering cutting-edge knowledge and business guidance. It aims to advance CGT drug R&D in China and share valuable insights from Chinese scholars with the global community engaged in related fields. She also emphasized that TUP will continue to foster in-depth exchanges and collaboration with all stakeholders, and will consistently publish high-level academic monographs and journals, so as to contribute to a healthier China.